Rubric Capital Management LP Revance Therapeutics, Inc. Transaction History

Rubric Capital Management LP

  • $3.59 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$4.65 - $9.31 $5.56 Million - $11.1 Million
1,195,373 Added 81.79%
2,656,847 $13.1 Million
Q4 2023

Feb 13, 2024
SELL
$5.81 - $11.2 $804,836 - $1.55 Million
-138,526 Reduced 8.66%
1,461,474 $12.8 Million
Q3 2023

Nov 14, 2023
BUY
$11.47 - $25.07 $18.4 Million - $40.1 Million
1,600,000 New
1,600,000 $18.4 Million

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email